DocSym
β
Searchsearch
Search
(A96.1) Machupo haemorrhagic fever
More details coming soon
929 in individuals diagnosis machupo haemorrhagic fever confirmed
Diagnosis machupo haemorrhagic fever is diagnosed Women are 25.30% more likely than Men
347
Men receive the diagnosis machupo haemorrhagic fever
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
582
Women receive the diagnosis machupo haemorrhagic fever
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease machupo haemorrhagic fever - Men aged 80-84 and Women aged 65-69
In Men diagnosis is most often set at age 80-84
Less common in men the disease occurs at Age 0-79, 85-95+Less common in women the disease occurs at Age 0-64, 70-74, 80-95+
In Women diagnosis is most often set at age 65-69, 75-79
Disease Features machupo haemorrhagic fever
Absence or low individual and public risk
Machupo haemorrhagic fever - what does this mean
Machupo haemorrhagic fever is caused by a virus transmitted by rodents, and is spread to humans through contact with infected rodents or their excretions. the virus can also be spread from person to person through contact with the body fluids of an infected individual. symptoms of the disease include fever, headache, muscle ache, rash, and bleeding from the mouth, nose, and other mucous membranes.
What happens during the disease - machupo haemorrhagic fever
Machupo haemorrhagic fever is caused by the machupo virus, a member of the arenaviridae family of viruses. the virus is transmitted to humans through contact with the urine, saliva or feces of infected rodents, most commonly the long-tailed mouse. once the virus enters the body, it replicates in the reticuloendothelial system, leading to systemic infection and a wide range of symptoms that can include fever, headache, muscle pain, nausea, and vomiting. in severe cases, the infection can lead to haemorrhage, shock, and death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests for antibodies
- Serological tests for antibodies
- Urine analysis
- Imaging studies such as X-rays, CT scans, or MRI
- Polymerase chain reaction (PCR) tests
- Liver function tests
- Throat swab
- Stool sample
Treatment and Medical Assistance
Main goal: Treat the symptoms and reduce the risk of complications of Machupo haemorrhagic fever.
- Administer antiviral medications, such as ribavirin, to reduce the severity and duration of the illness.
- Provide supportive care, such as IV fluids and oxygen, to treat dehydration, hypotension, and respiratory distress.
- Monitor vital signs, such as temperature, pulse, and blood pressure, to assess the patient's condition.
- Perform laboratory tests, such as complete blood count, to evaluate the patient's health status.
- Administer medications, such as pain relievers, to control fever and pain.
- Prescribe antibiotics to prevent or treat secondary infections.
- Provide education to the patient and family about the disease and its treatment.
- Provide emotional support to the patient and family.
- Refer the patient to a specialist, such as an infectious disease specialist, for further evaluation and treatment.
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Machupo haemorrhagic fever - Prevention
The best way to prevent machupo haemorrhagic fever is to avoid contact with rodents, especially the wild rodents that are known to carry the machupo virus. it is also important to practice good hygiene and to avoid contaminated food and water sources. vaccines are available for those who are at high risk of infection.